These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9810693)

  • 1. Studies on 5-lipoxygenase inhibitors. II. Discovery, optical resolution and enantioselective synthesis of FR110302, a highly potent non-redox type 5-lipoxygenase inhibitor.
    Yatabe T; Kayakiri H; Kawai Y; Oku T; Tanaka H
    Chem Pharm Bull (Tokyo); 1998 Oct; 46(10):1556-65. PubMed ID: 9810693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 5-lipoxygenase inhibitor, FR110302, suppresses airway hyperresponsiveness and lung eosinophilia induced by Sephadex particles in rats.
    Asano M; Inamura N; Nakahara K; Nagayoshi A; Isono T; Hamada K; Oku T; Notsu Y; Kohsaka M; Ono T
    Agents Actions; 1992 Jul; 36(3-4):215-21. PubMed ID: 1382375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
    Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
    J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
    Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
    Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 5-lipoxygenase inhibitor, FR110302, inhibits ozone-induced airway hyperresponsiveness in guinea pigs and dogs.
    Asano M; Imai T; Inoue H; Masunaga T; Inamura N; Yatabe T; Hiroi J; Nakahara K; Notsu Y; Takishima T
    Agents Actions; 1993 Mar; 38(3-4):171-7. PubMed ID: 8213343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivatives of 2-[[N-(Aminocarbonyl)-N-hydroxyamino]methyl]-1,4- benzodioxan as orally active 5-lipoxygenase inhibitors.
    Satoh Y; Powers C; Toledo LM; Kowalski TJ; Peters PA; Kimble EF
    J Med Chem; 1995 Jan; 38(1):68-75. PubMed ID: 7837242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro pharmacology of BAY X1005, a new inhibitor of leukotriene synthesis.
    Fruchtmann R; Mohrs KH; Hatzelmann A; Raddatz S; Fugmann B; Junge B; Horstmann H; Müller-Peddinghaus R
    Agents Actions; 1993 Mar; 38(3-4):188-95. PubMed ID: 8213345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on 5-lipoxygenase inhibitors. I. Synthesis and 5-lipoxygenase-inhibitory activity of novel hydroxamic acid derivatives.
    Yatabe T; Kawai Y; Oku T; Tanaka H
    Chem Pharm Bull (Tokyo); 1998 Jun; 46(6):966-72. PubMed ID: 9658575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816.
    Hutchinson JH; Riendeau D; Brideau C; Chan C; Delorme D; Denis D; Falgueyret JP; Fortin R; Guay J; Hamel P
    J Med Chem; 1993 Sep; 36(19):2771-87. PubMed ID: 8410991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists.
    Musser JH; Chakraborty UR; Sciortino S; Gordon RJ; Khandwala A; Neiss ES; Pruss TP; Van Inwegen R; Weinryb I; Coutts SM
    J Med Chem; 1987 Jan; 30(1):96-104. PubMed ID: 3806607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530.
    Dubé D; Blouin M; Brideau C; Chan CC; Desmarais S; Ethier D; Falgueyret JP; Friesen RW; Girard M; Girard Y; Guay J; Riendeau D; Tagari P; Young RN
    Bioorg Med Chem Lett; 1998 May; 8(10):1255-60. PubMed ID: 9871745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of [[(naphthalenylmethoxy)- and [[(quinolinylmethoxy)phenyl]amino]oxoalkanoic acid esters. A novel series of leukotriene D4 antagonists and 5-lipoxygenase inhibitors.
    Musser JH; Kubrak DM; Chang J; Lewis AJ
    J Med Chem; 1986 Aug; 29(8):1429-35. PubMed ID: 3090264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, antioxidant properties, biological activity and molecular modelling of a series of chalcogen analogues of the 5-lipoxygenase inhibitor DuP 654.
    Engman L; Stern D; Frisell H; Vessman K; Berglund M; Ek B; Andersson CM
    Bioorg Med Chem; 1995 Sep; 3(9):1255-62. PubMed ID: 8564418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetrical bis(heteroarylmethoxyphenyl)alkylcarboxylic acids as inhibitors of leukotriene biosynthesis.
    Kolasa T; Gunn DE; Bhatia P; Basha A; Craig RA; Stewart AO; Bouska JB; Harris RR; Hulkower KI; Malo PE; Bell RL; Carter GW; Brooks CD
    J Med Chem; 2000 Aug; 43(17):3322-34. PubMed ID: 10966751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pyrrolo(2,3-c)quinolines and pyrrolo(3,4-d)quinolines--synthesis and investigation of lipoxygenase inhibition].
    Görlitzer K; Fabian J; Frohberg P; Drutkowski G
    Pharmazie; 2002 Apr; 57(4):243-9. PubMed ID: 11998442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of indolylalkoxyiminoalkylcarboxylates as leukotriene biosynthesis inhibitors.
    Kolasa T; Bhatia P; Brooks CD; Hulkower KI; Bouska JB; Harris RR; Bell RL
    Bioorg Med Chem; 1997 Mar; 5(3):507-14. PubMed ID: 9113329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of a series of hydroxamic acid derivatives on 5-lipoxygenase and cyclooxygenase from neutrophils and 12-lipoxygenase from platelets and their in vivo effects on inflammation and anaphylaxis.
    Huang FC; Shoupe TS; Lin CJ; Lee TD; Chan WK; Tan J; Schnapper M; Suh JT; Gordon RJ; Sonnino PA
    J Med Chem; 1989 Aug; 32(8):1836-42. PubMed ID: 2502629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naphthalenic lignan lactones as selective, nonredox 5-lipoxygenase inhibitors. Synthesis and biological activity of (methoxyalkyl)thiazole and methoxytetrahydropyran hybrids.
    Ducharme Y; Brideau C; Dubé D; Chan CC; Falgueyret JP; Gillard JW; Guay J; Hutchinson JH; McFarlane CS; Riendeau D
    J Med Chem; 1994 Feb; 37(4):512-8. PubMed ID: 8120869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective metabolism of the 5-lipoxygenase inhibitor A-78773.
    Carter GW; Bell RL; Marsh K; Lanni C; Awni WM; Bouska J; Stewart AO; Hansen R; Dubé L; Brooks DW
    Ann N Y Acad Sci; 1994 Nov; 744():262-73. PubMed ID: 7825849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
    Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
    Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.